8-Chloro-5-methyl-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine

ID: ALA266723

PubChem CID: 11724853

Max Phase: Preclinical

Molecular Formula: C19H21ClN4

Molecular Weight: 340.86

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(C2=Nc3cc(Cl)ccc3N(C)c3ccccc32)CC1

Standard InChI:  InChI=1S/C19H21ClN4/c1-22-9-11-24(12-10-22)19-15-5-3-4-6-17(15)23(2)18-8-7-14(20)13-16(18)21-19/h3-8,13H,9-12H2,1-2H3

Standard InChI Key:  XQIPQCHREHNRDI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    5.5667   -6.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7542   -6.2667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0875   -5.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1667   -4.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2250   -5.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9042   -4.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4125   -4.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5667   -7.0917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4292   -5.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5417   -8.7292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8042   -4.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8417   -7.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2667   -7.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8292   -5.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2625   -8.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8375   -8.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1667   -3.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9042   -5.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -4.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0167   -5.5125    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.5292   -4.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5292   -9.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5375   -5.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3500   -4.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  6  1  0
  5  2  1  0
  6  3  2  0
  7  5  2  0
  8  1  1  0
  9  5  1  0
 10 15  1  0
 11  7  1  0
 12  8  1  0
 13  8  1  0
 14  9  2  0
 15 13  1  0
 16 12  1  0
 17  4  1  0
 18  3  1  0
 19 14  1  0
 20 14  1  0
 21  6  1  0
 22 10  1  0
 23 18  2  0
 24 23  1  0
 16 10  1  0
  4  7  1  0
 24 21  2  0
 11 19  2  0
M  END

Associated Targets(Human)

DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine receptors; D2 & D4 (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH4 Tchem Histamine H4 receptor (3997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd5 Dopamine receptor (1304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2a Serotonin 2a (5-HT2a) receptor (3540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr2c Serotonin 2c (5-HT2c) receptor (1134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr3a Serotonin 3 (5-HT3) receptor (1834 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 340.86Molecular Weight (Monoisotopic): 340.1455AlogP: 3.75#Rotatable Bonds:
Polar Surface Area: 22.08Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.35CX LogP: 3.62CX LogD: 3.35
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.73Np Likeness Score: -0.81

References

1. de Paulis T, Betts CR, Smith HE, Mobley PL, Manier DH, Sulser F..  (1981)  Synthesis of clozapine analogues and their affinity for clozapine and spiroperidol binding sites in rat brain.,  24  (9): [PMID:7288815] [10.1021/jm00141a001]
2. Phillips ST, de Paulis T, Baron BM, Siegel BW, Seeman P, Van Tol HH, Guan HC, Smith HE..  (1994)  Binding of 5H-dibenzo[b,e][1,4]diazepine and chiral 5H-dibenzo[a,d]cycloheptene analogues of clozapine to dopamine and serotonin receptors.,  37  (17): [PMID:8064797] [10.1021/jm00043a008]
3. Smits RA, Lim HD, Stegink B, Bakker RA, de Esch IJ, Leurs R..  (2006)  Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.,  49  (15): [PMID:16854056] [10.1021/jm051008s]

Source